Related Experiment Video
Updated: Jun 25, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor
1Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes of Biological Sciences, Shanghai, People's Republic of China.
Abstract:
Eph receptors, the largest subfamily of receptor tyrosine kinases, and their ephrin ligands play important roles in nervous system development. Recently, they have been implicated in tumorigenesis of different cancers. In this study, we showed that the expression of ephrinA5 was dramatically downregulated in primary gliomas compared with normal tissues. Forced expression of ephrinA5 reduced tumorigenicity of human glioma U373 cells. Epidermal growth factor receptor (EGFR), which frequently acts as an oncoprotein in glioma, was greatly decreased in ephrinA5-transfected glioma cells, and the two molecules exhibited a mutually exclusive expression pattern in primary glioma samples. We found that ephrinA5 enhanced c-Cbl binding to EGFR, thus promoted ubiquitylation and degradation of the receptor. Either ephrinA5-Fc or EphA2-Fc treatment simulating bidirectional signaling of Eph/ephrin system resulted in EGFR decrease. This study discovered that ephrinA5 acted as a tumor suppressor in glioma, and its negative regulation of EGFR contributed to the suppressive effects. In addition to identifying a novel mechanism underlying tumor suppressor activity of ephrinA5, we also showed cross-talk between different receptor tyrosine kinase families in glioma. These findings may improve therapeutic strategies for glioma.
Insights
EphrinA5 acts as a tumor suppressor in glioma by downregulating the epidermal growth factor receptor (EGFR). This discovery offers new insights into glioma development and potential therapeutic strategies.
Area of Science:
- Oncology
- Neuroscience
- Molecular Biology
Background:
- Eph receptors and ephrin ligands are crucial for nervous system development.
- These molecules are increasingly recognized for their roles in cancer, including glioma tumorigenesis.
Purpose of the Study:
- To investigate the role of ephrinA5 in glioma.
- To elucidate the mechanism by which ephrinA5 influences glioma cell behavior and its relationship with EGFR.
Main Methods:
- Analyzing ephrinA5 expression in primary gliomas.
- Forced expression of ephrinA5 in human glioma U373 cells.
- Assessing EGFR levels and its interaction with c-Cbl.
- Simulating bidirectional Eph/ephrin signaling using Fc-conjugated treatments.
Main Results:
- EphrinA5 expression was significantly downregulated in gliomas compared to normal tissues.
- Forced ephrinA5 expression reduced glioma cell tumorigenicity.
- EphrinA5 expression negatively correlated with EGFR levels, and ephrinA5 enhanced EGFR ubiquitylation and degradation via c-Cbl.
- Bidirectional Eph/ephrin signaling also led to decreased EGFR.
Conclusions:
- EphrinA5 functions as a tumor suppressor in glioma.
- The tumor-suppressive activity of ephrinA5 is mediated by its negative regulation of EGFR.
- This study reveals cross-talk between Eph/ephrin and EGFR signaling pathways in glioma, offering potential therapeutic targets.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...